QSAM Biosciences, Inc.
A408WA
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 2.78M | 3.34M | 3.51M | 3.78M | 4.44M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 3.94M | 4.68M | 4.73M | 4.76M | 5.46M |
Operating Income | -3.94M | -4.68M | -4.73M | -4.76M | -5.46M |
Income Before Tax | -4.39M | -5.09M | -5.15M | -5.20M | -5.48M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -4.39 | -5.09 | -5.15 | -5.20 | -5.48 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -4.39M | -5.09M | -5.15M | -5.20M | -5.48M |
EBIT | -3.94M | -4.68M | -4.73M | -4.76M | -5.46M |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -- | -- | -- | -- | -- |
Normalized Basic EPS | -- | -- | -- | -- | -- |
EPS Diluted | -- | -- | -- | -- | -- |
Normalized Diluted EPS | -- | -- | -- | -- | -- |
Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |